Table 4 Type-specific HPV prevalences with exact binomial 95% confidence intervals (CI) by histologically confirmed cervical lesion

From: Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

 

Histological diagnosis

 

No lesion ( n =181)

CIN 1 ( n =71)

CIN 2 ( n =104)

CIN 3+ ( n =63)

Type(s)

n

% (95% CI)

n

% (95% CI)

n

% (95% CI)

n

% (95% CI)

HPV 16

28

15.5 (10.5–21.6)

11

15.5 (8.0–26.0)

40

38.5 (29.1–48.5)

38

60.3 (47.2–72.4)

HPV 18

12

6.6 (3.5–11.3)

4

5.6 (1.6–13.8)

6

5.8 (2.1–12.1)

2

3.2 (0.4–11.0)

HPV 31

20

11.0 (6.9–16.5)

4

5.6 (1.6–13.8)

24

23.1 (15.4–32.4)

8

12.7 (5.6–23.5)

HPV 33

13

7.2 (3.9–12.0)

5

7.0 (2.3–15.7)

6

5.8 (2.1–12.1)

5

7.9 (2.6–17.6)

HPV 35

4

2.2 (0.6–5.6)

2

2.8 (0.3–9.8)

4

3.8 (1.1–9.6)

1

1.6 (0.04–8.5)

HPV 39

11

6.1 (3.1–10.6)

3

4.2 (0.9–11.9)

4

3.8 (1.1–9.6)

1

1.6 (0.04–8.5)

HPV 45

8

4.4 (1.9–8.5)

3

4.2 (0.9–11.9)

3

2.9 (0.6–8.2)

1

1.6 (0.04–8.5)

HPV 51

19

10.5 (6.4–15.9)

13

18.3 (10.1–29.3)

4

3.8 (1.1–9.6)

1

1.6 (0.04–8.5)

HPV 52

10

5.5 (2.7–9.9)

1

1.4 (0.04–7.6)

7

6.7 (2.7–13.4)

5

7.9 (2.6–17.6)

HPV 56

18

9.9 (6.0–15.3)

5

7.0 (2.3–15.7)

2

1.9 (0.2–6.8)

2

3.2 (0.4–11.0)

HPV 58

11

6.1 (3.1–10.6)

4

5.6 (1.6–13.8)

7

6.7 (2.7–13.4)

3

4.8 (1.0–13.3)

Group 1/2 Aa

136

75.1 (68.2–81.3)

51

71.8 (59.9–81.9)

88

84.6 (76.2–90.9)

57

90.5 (80.4–96.4)

Group 2Bb

23

12.7 (8.2–18.5)

13

18.3 (10.1–29.3)

4

3.8 (1.1–9.6)

1

1.6 (0.04–8.5)

Any HPV

163

90.1 (84.7–94.0)

65

91.5 (82.5–96.8)

92

88.5 (80.7–93.9)

58

92.1 (82.4–97.4)

  1. aInfection with one or more Group 1/2A HPV type (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), coinfection with HPV types of Group 2B and/or Group 3 allowed.
  2. bInfection with one or more Group 2B HPV type (26, 30, 53, 66, 67, 69, 70, 73 and 82), coinfection with HPV types of Group 3 allowed.
Back to article page